Under tranche 1, 16 investments for large scale electronics (worth over US$1.5 billion) were approved, with 215 and 28 applications received for pharmaceuticals and medical devices respectively. Detailed schemes for the second tranche are expected shortly.
Launched under the Atmanirbhar Bharat initiative, this announcement comes at an opportune time when global investors are considering diversifying their manufacturing presence outside China (popularly called the China plus one strategy).
Manufacturers in India are also offered incentives packages by the states, allowing them to recoup approximately 30%-100% of their investment. These usually comprise of:
- Capital linked incentives with subsidy as a percentage of investment
- Expenditure linked incentives like power tariff subsidies, stamp duty reimbursement
- Sales linked incentives like SGST reimbursement, turnover based subsidy
States also offer significant investments (‘mega’ units) customized incentives packages.
Investors can avail incentives from both the Centre and the State simultaneously. The central government also attempts to provide financial relief to industry through measures like duty scrips on foreign trade transactions and reduced corporate tax rates.
Therefore, investors should extensively evaluate and pursue all incentives avenues to benefit from the holistic support intended by the government.
Since the success of these initiatives hinges on their implementation, the government should ensure swift approvals with timely appraisal and disbursal of funds, for all such scheme.
Extension of incentives to encompass service providers and globally relevant areas such as climate change and sustainability will be welcomed as next steps. Ultimately, such end to end support from policy makers might position India as a lucrative global manufacturing destination.
(The article is authored by Bhavesh Thakkar, Partner, Indirect Tax, EY India, with contribution from Prutha Pathak, Manager, Indirect Tax, EY India.)